Header Logo

Connection

KENNETH MCCLAIN to Thalidomide

Back to Details
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Thalidomide.
KENNETH MCCLAIN
Connection Strength
0.316
Thalidomide
  1. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007 Jan; 48(1):44-9.
    View in: PubMed
    Score: 0.257
  2. Drug therapy for the treatment of Langerhans cell histiocytosis. Expert Opin Pharmacother. 2005 Nov; 6(14):2435-41.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.